Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Family Practice|May 30, 2006
Perceptions and behaviours of women with bladder control problemsAnanias C Diokno, Peter K Sand, Scott Macdiarmid, et al.Clinical Drug Investigation|August 23, 2012
Cognitive effects of oxybutynin chloride topical gel in older healthy subjects: a 1-week, randomized, double-blind, placebo- and active-controlled studyGary G Kay, David R Staskin, Scott MacDiarmid, et al.Urology|November 17, 2009
Efficacy and tolerability of fesoterodine in men with overactive bladder: a pooled analysis of 2 phase III studiesSender Herschorn, J Stephen Jones, Matthias Oelke, et al.The Journal of Urology|April 15, 2018
Efficacy and Safety of SER120 Nasal Spray in Patients with Nocturia: Pooled Analysis of 2 Randomized, Double-Blind, Placebo Controlled, Phase 3 TrialsJed Kaminetsky, Seymour Fein, Roger Dmochowski, et al.Current Urology Reports|August 16, 2012
Percutaneous tibial nerve stimulation: a clinically and cost effective addition to the overactive bladder algorithm of careDavid R Staskin, Kenneth M Peters, Scott MacDiarmid, et al.European Urology Focus|September 17, 2017
Treating Overactive Bladder in Older Patients with a Combination of Mirabegron and Solifenacin: A Prespecified Analysis from the BESIDE StudyWilliam Gibson, Scott MacDiarmid, Moses Huang, et al.International Urogynecology Journal and Pelvic Floor Dysfunction|May 26, 2006
Effectiveness and tolerability of extended-release oxybutynin vs extended-release tolterodine in women with or without prior anticholinergic treatment for overactive bladderRodney U Anderson, Scott MacDiarmid, Sherron Kell, et al.Female Pelvic Medicine & Reconstructive Surgery|May 10, 2022
Six-Month Outcomes of Reimplantation of a Coin-Sized Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome With Urgency Urinary IncontinenceBilal Kaaki, Sharon English, Peter Gilling, et al.Neurourology and Urodynamics|September 25, 2023
Efficacy and safety of an alternative onabotulinumtoxinA injection paradigm for refractory overactive bladderScott MacDiarmid, David B Glazier, Rebecca J McCrery, et al.The Patient|June 25, 2017
Assessing Preference-Based Outcome Measures for Overactive Bladder: An Evaluation of Patient-Reported Outcome Data from the BESIDE Clinical TrialMike Herdman, Jameel Nazir, Zalmai Hakimi, et al.Pageof 4